1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Currentpartnering
21 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020

  • $ 3495
  • April 2020
  • 400 pages

Lymphoma Society, LifeLink Foundation, LifeLiver, LifeQ, LineaRx, Lipidor, LogicNets, Loreal, Louisiana State University, Loxo Oncology, Lupin Limited, Luye Pharma Group, Macrogen, MAKScientific, Mallinckrodt Pharmaceuticals, Marina Biotech, Marshall Institute for Interdisciplinary Research

  • Biotechnology
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Global Oncology Partnering 2014-2020: Deal trends, players and financials

  • $ 3495
  • May 2020
  • 2500 pages

Lymphoma, Hodgkin’s lymphoma, Non Hodgkin’s lymphoma, Melanoma, Mesothelioma, Metastases, Bone metastases, Multiple myeloma, Neuroblastoma, Non-melanoma skin cancer, Ovarian cancer, Pancreatic cancer, Prostate cancer, Renal cell carcinoma, Sarcoma, Solid tumors, Testicular cancer, Thyroid c

  • Lymphoma
  • Orphan Disease
  • Pharmaceutical
  • Therapy
  • United States

Global Hematology Partnering 2010-2020: Deal trends, players and financials

  • $ 3495
  • June 2020
  • 400 pages

Lymphoma Research, Leukemia & Lymphoma Society, Lev Pharmaceuticals, LFB Biomedicaments, LFB Biotechnologies, LifeHealth, Ligand Pharmaceuticals, Lonza, Loop Medical, LUNAC Therapeutics, Mallinckrodt Pharmaceuticals, MannKind Biopharmaceuticals, Mantecorp, Maruho, Masimo, Massa

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States
  • Demand

Global Diagnostics Partnering Terms and Agreements 2014-2020

  • $ 3495
  • May 2020
  • 1000 pages

Lymphoma Society, LG Life Sciences, Lonza, Lumos Pharma, Lupagen, MAB Discovery, Mabion, MabVax Therapeutics, mAbXience, Macquarie University, Macrogenics, Mapp Biopharmaceutical, Massachusetts General Hospital, Mayo Clinic, MD Anderson Cancer Center, MedImmune, Medison Pharma, Medivation,

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • United States

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020

  • $ 3495
  • May 2020
  • 300 pages

Hussman Foundation, Johns Hopkins University, Johnson & Johnson Innovation, JSC Binnopharm, JSC Pharmadis, Juvaris BioTherapeutics, KAEL-GemVax, KellBenx, Kindred Bio, Leukaemia & Lymphoma Research, LG Life Sciences, Ligand Pharmaceuticals, Lineage Cell Therapeutics, LineaRx, London

  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • United States

Global Cancer Diagnostics Partnering Terms and Agreements 2014-2020

  • $ 3495
  • May 2020
  • 450 pages

Lymphoma Research, Leukocare, LG Life Sciences, LineaRx, Los Angeles Biomedical Research Institute, Louisiana State University, Lumos Pharma, Lund University, Lung Cancer Research Foundation, MabVax Therapeutics, Madison Vaccines, Massachusetts General Hospital, Matrivax, Mayo Clinic, MBF T

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Vaccine
  • United States

Global Academic and Non-Profit Partnering Terms and Agreements 2014-2020: Deal trends, players and financials

  • $ 3495
  • March 2020
  • 2500 pages

Lymphoma Research, Leukemia & amp; Lymphoma Society, Levine Cancer Institute, Leviticus Cardio, LexaGene, Lexicon Pharmaceuticals, Lexogen, LGS Foundation, Lhasa, Libbs Farmaceutica, Lieber Institute, LifeArc, LifeLink Foundation, LifeMap Sciences, LifeMap Solutions, LifeOmic, L

  • Hospital
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2020

  • $ 3495
  • March 2020
  • 1300 pages

Lymphoma Foundation, Cyclacel Pharmaceuticals, Cycle Pharmaceuticals, Cyclopharm, Cyclo Therapeutics, CymaBay Therapeutics, Cynapsus Therapeutics, Cyntec, Cynvenio, Cyon Therapeutics, Cyprium Therapeutics, Cyrenaic Pharmaceuticals, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Ther

  • Biopharmaceutical
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Global Proteomics Partnering Terms and Agreements 2010 to 2020

  • $ 3495
  • June 2020
  • 400 pages

Lymphoma Society, LifeArc, LifeMap Sciences, Life Technologies, Ligand Pharmaceuticals, Link Medicine, Lipimetix, LipimetiX Development, Lonza, Loreal, Lucigen, Lundbeck, Luxembourg Institute of Health, Magellan Biosciences, Maine Manufacturing, Margaret Q Landenberger Research Foundation,

  • Lymphoma
  • Pharmaceutical
  • Proteomics
  • Therapy
  • United States

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020

  • $ 3495
  • June 2020
  • 500 pages

Lymphoma Society, LG Life Sciences, Libbs Farmaceutica, LifeArc, Ligand Pharmaceuticals, Liverpool School of Tropical Medicine, Livzon Mabpharm, Lonza, Lpath, Lumos Pharma, Lupagen, Lupin, Lupus Therapeutics, MAB Discovery, Mabion, MabQuest, MAbSilico, Mabspace Bioscience, MabVax Therapeuti

  • Lymphoma
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • United States

Global Immunology Partnering 2014-2020: Deal trends, players and financials

  • $ 3495
  • June 2020
  • 500 pages

Lymphoma Society, LG Life Sciences, LifeArc, LifeMax Laboratories, Ligand Pharmaceuticals, Lipum, LNC, Lonza, Lubeck Institute of Experimental Dermatology, Luminex, Lumiphore, Lupin, Lupus Foundation of America (LFA), Lupus Research Alliance, Lupus Research Institute, Lupus Therapeutics, Lu

  • Immunology
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Global Genomics Partnering Terms and Agreements 2014 to 2020

  • $ 3495
  • June 2020
  • 550 pages

Lymphoma Society, LGC, LGS Foundation, Lieber Institute, Lifecode, LifeLabs Medical Laboratory Services, LifeMap Sciences, LifeNome, Lineagen, Linkage Biosciences, Liquid Biotech USA, Lockheed Martin, LogicBio Therapeutics, Lonza, Louisiana State University, Loxo Oncology, Lucigen, Ludwig-M

  • Genomics
  • Genomics Proteomics And Enabling Technology
  • Health Services
  • Lymphoma
  • United States

Global Regenerative Medicine Partnering Terms and Agreements 2014 to 2020

  • $ 3495
  • June 2020
  • 750 pages

Lymphoma Society, LG Life Sciences, LifeCell, LifeLiver, LifeSouth Community Blood Centers, Ligand Pharmaceuticals, Lineage Cell Therapeutics, LineaRx, Live Like Bella Childhood Cancer Foundation, Liventa Biosciences, Locana, LogicBio Therapeutics, Longeveron, Lonza, Lorem Vascular, Loughbo

  • Lymphoma
  • Pharmaceutical
  • Regenerative Medicine
  • Therapy
  • United States

Global Bioinformatics Partnering Terms and Agreements 2014 to 2020

  • $ 3495
  • June 2020
  • 600 pages

Lymphoma Society, Levelblox, Lieber Institute, Life Image, LifeMap Sciences, LifeNome, LifeOmic, LifeScan, LifeServe Blood Center, Limbix, Lineagen, Linguamatics, LiquidHub, Litesprite, Livongo Health, LLamasoft, Lockheed Martin, LogicNets, Logic PD, London Medical Databases, Lord Global, L

  • Bioinformatics
  • Healthcare
  • Hospital
  • Lymphoma
  • United States

Global Artificial Intelligence (AI) Partnering Terms and Agreements 2014 to 2020

  • $ 3495
  • May 2020
  • 250 pages

Lymphoma Society, LGS Foundation, Lifecode, LifeLabs Medical Laboratory Services, LifeOmic, Li Ka Shing Foundation, LineaRx, Lipotype, Liquid Biotech USA, Livongo Health, Lockheed Martin, Locus Biosciences, Louisiana State University, Loxo Oncology, Lucid Diagnostics, Lumiphore, Lundbeck, L

  • Health Services
  • Lymphoma
  • Pharmaceutical
  • Specialty Hospital
  • United States

Global Biomarker Partnering Terms and Agreements 2014-2020: Deal trends, players and financials

  • $ 3495
  • May 2020
  • 300 pages

Lymphoma Society, LG Life Sciences, Libbs Farmaceutica, LifeArc, Ligand Pharmaceuticals, Liverpool School of Tropical Medicine, Livzon Mabpharm, Lonza, Lpath, Ludwig-Maximilians University, Ludwig Institute for Cancer Research, Lumiphore, Lumos Pharma, Lundbeck, Lund University, Lupagen, Lu

  • Lymphoma
  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • United States

Global Vaccine Partnering Terms and Agreements 2014-2020: Deal trends, players and financials

  • $ 3495
  • May 2020
  • 400 pages

Lymphoma Foundation, CvergenX, CyberKnife, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cyclica, Cyclopharm, Cyclotek, Cynata Therapeutics, Cyntec, Cynvenio, Cyteir Therapeutics, CytImmune Science, CYTLIMIC, Cytodyn, CytoLumina Technologies, CytomX Therapeutics, Cytori Therapeutics, Cytos Bi

  • Lymphoma
  • Oncology
  • Pharmaceutical
  • Therapy
  • United States

Global Pharmaceutical Partnering Terms and Agreements 2014-2020: Deal trends, players and financials

  • $ 3495
  • March 2020
  • 4000 pages

Lymphoma Foundation, CVC Capital Partners, CVie, CVS Caremark, CV Sciences, CVS Pharmacy, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cycle Pharmaceuticals, Cyclerion Therapeutics, Cyclica, Cyclotek, Cyclo Therapeutics, CyDex, CymaBay Therapeutics, Cynapsus Therapeutics, Cynata Therapeutics

  • Biotechnology
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Global Big Pharma Partnering Terms and Agreements 2014-2020: Deal trends, players and financials

  • $ 3495
  • March 2020
  • 1800 pages

Lymphoma Society, Lexicon Pharmaceuticals, Lieber Institute, LifeArc, LifeMax Laboratories, Ligand Pharmaceuticals, Lilly Endowment, Lincoln Equities Group, Lipigon Pharmaceuticals, Litha Pharma, Liverpool School of Tropical Medicine, Living Proof, Livongo Health, LLamasoft, Locemia Solutio

  • Biopharmaceutical
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2020

  • $ 3495
  • March 2020
  • 1500 pages

Lymphoma Society, LexaGene, Lexogen, LGC, LG Life Sciences, Lhasa, Lieber Institute, LifeArc, LifeMap Sciences, Ligand Pharmaceuticals, Li Ka Shing Foundation, Lineage Cell Therapeutics, LineaRx, LipimetiX Development, Lipotype, Liverpool School of Tropical Medicine, Livongo Health, LNC, Lo

  • Biotechnology
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on